| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Pathways |
Authors' Affiliations: 1 M&M Medical BioInformatics, Hongo, Japan and 2 Genetics and Cell Biology Section, National Cancer Center Research Institute, Tokyo, Japan
Requests for reprints: Masaru Katoh, Genetics and Cell Biology Section, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan. Phone: 81-3-3542-2511; Fax: 81-3-3541-2685; E-mail: mkatoh-kkr{at}umin.ac.jp.
Abstract
WNT signals are transduced to the canonical pathway for cell fate determination, and to the noncanonical pathway for control of cell movement and tissue polarity. Canonical WNT signals are transduced through Frizzled family receptors and LRP5/LRP6 coreceptor to the ß-catenin signaling cascade. Microtubule affinity–regulating kinase (PAR-1) family kinases, casein kinase I
(CKI
), and FRAT are positive regulators of the canonical WNT pathway, whereas APC, AXIN1, AXIN2, CKI
, NKD1, NKD2, ßTRCP1, ßTRCP2, ANKRD6, Nemo-like kinase (NLK), and peroxisome proliferator–activated receptor
(PPAR
) are negative regulators. Nuclear complex, consisting of T-cell factor/lymphoid enhancer factor, ß-catenin, BCL9/BCL9L, and PYGO, activates transcription of canonical WNT target genes such as FGF20, DKK1, WISP1, MYC, CCND1, and Glucagon (GCG). Noncanonical WNT signals are transduced through Frizzled family receptors and ROR2/RYK coreceptors to the Dishevelled-dependent (Rho family GTPases and c-jun NH2-terminal kinase) or the Ca2+-dependent (NLK and nuclear factor of activated T cells) signaling cascades. WNT signals are context-dependently transduced to both pathways based on the expression profile of WNT, SFRP, WIF, DKK, Frizzled receptors, coreceptors, and the activity of intracellular WNT signaling regulators. Epigenetic silencing and loss-of-function mutation of negative regulators of the canonical WNT pathway occur in a variety of human cancer. WNT, fibroblast growth factor (FGF), Notch, Hedgehog, and transforming growth factor ß/bone morphogenetic protein signaling network are implicated in the maintenance of tissue homeostasis by regulating self-renewal of normal stem cells as well as proliferation or differentiation of progenitor (transit-amplifying) cells. Breakage of the stem cell signaling network leads to carcinogenesis. Nonsteroidal anti-inflammatory drugs and PPAR
agonists with the potential to inhibit the canonical WNT signaling pathway are candidate agents for chemoprevention. ZTM000990 and PKF118-310 are lead compounds targeted to the canonical WNT signaling cascade. Anti-WNT1 and anti-WNT2 monoclonal antibodies show in vitro effects in cancer treatment. After the optimization, derivatives of small-molecule compound and human monoclonal antibody targeted to the WNT signaling pathway could be used in cancer medicine.
This article has been cited by other articles:
![]() |
I. Sakata, J. Yang, C. E. Lee, S. Osborne-Lawrence, S. A. Rovinsky, J. K. Elmquist, and J. M. Zigman Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E134 - E141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hussain, M. Rao, A. E. Humphries, J. A. Hong, F. Liu, M. Yang, D. Caragacianu, and D. S. Schrump Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells Cancer Res., April 15, 2009; 69(8): 3570 - 3578. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ashihara, E. Kawata, Y. Nakagawa, C. Shimazaski, J. Kuroda, K. Taniguchi, H. Uchiyama, R. Tanaka, A. Yokota, M. Takeuchi, et al. {beta}-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model Clin. Cancer Res., April 15, 2009; 15(8): 2731 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. Shah, A. Muralidharan, M. Gokulgandhi, K. Soan, and S. Thomas Cadherin Switching and Activation of {beta}-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer J. Biol. Chem., January 9, 2009; 284(2): 1018 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V Shah, S. Thomas, A. Muralidharan, Y. Liu, P. L Hermonat, J. Williams, and J. Chaudhary Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways Endocr. Relat. Cancer, December 1, 2008; 15(4): 953 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-R. Wei, J. B. Edwards, S. B. Hoover, H. S. Tillman, L. T. Reed, R. C. Sills, and R. M. Simpson Altered {beta}-Catenin Accumulation in Hepatocellular Carcinomas of Diethylnitrosamine-Exposed Rhesus Macaques Toxicol Pathol, December 1, 2008; 36(7): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajashekhar, D. O. Traktuev, W. C. Roell, B. H. Johnstone, S. Merfeld-Clauss, B. Van Natta, E. D. Rosen, K. L. March, and M. Clauss IFATS Collection: Adipose Stromal Cell Differentiation Is Reduced by Endothelial Cell Contact and Paracrine Communication: Role of Canonical Wnt Signaling Stem Cells, October 1, 2008; 26(10): 2674 - 2681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Malhotra, Y. Baba, K. P. Garrett, F. J. T. Staal, R. Gerstein, and P. W. Kincade Contrasting Responses of Lymphoid Progenitors to Canonical and Noncanonical Wnt Signals J. Immunol., September 15, 2008; 181(6): 3955 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doghman, J. Cazareth, and E. Lalli The T cell factor/{beta}-Catenin Antagonist PKF115-584 Inhibits Proliferation of Adrenocortical Carcinoma Cells J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3222 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E.P. Prince and L. E. Ailles Cancer Stem Cells in Head and Neck Squamous Cell Cancer J. Clin. Oncol., June 10, 2008; 26(17): 2871 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Ricci-Vitiani, A Pagliuca, E Palio, A Zeuner, and R De Maria Colon cancer stem cells Gut, April 1, 2008; 57(4): 538 - 548. [Full Text] [PDF] |
||||
![]() |
X.-Z. Wu Origin of Cancer Stem Cells: The Role of Self-Renewal and Differentiation Ann. Surg. Oncol., February 1, 2008; 15(2): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |